Kimberly-Clark Buys Ballard--The Device Industry's No Man's Land
Executive SummaryWhile Kimberly-Clark's acquisition of Ballard Medical Products doesn't have the seismic impact of Medtronic's acquisition of Arterial Vascular Engineering, it's still a big deal--nearly three-quarters of a billion dollars in size. More importantly, it represents the kind of deal-making that is relevant to most hospital supply and device companies.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.